LON:VLG

Venture Life Group Interim Earnings Results & Report

Venture Life Group logo
GBX 69.14 +0.14 (+0.20%)
As of 12:37 PM Eastern

Venture Life Group reported Interim earnings on March 31, 2026. The company reported EPS of -GBX 1.49, while revenue was £35.17 million.

Earnings Announcement Details

Quarter
Interim
Report Date

Venture Life Group EPS Results

Actual EPS
-GBX 1.49
Consensus EPS
N/A
Beat/Miss
N/A
One Year Ago EPS
N/A

Venture Life Group Revenue Results

Actual Revenue
£35.17 million
Expected Revenue
N/A
Beat/Miss
N/A
YoY Revenue Growth
N/A

Conference Call Resources

Venture Life Group Interim Earnings FAQ

Venture Life Group (LON:VLG) reported earnings of -GBX 1.49 per share for Interim. The report was announced on Tuesday, March 31, 2026.

Venture Life Group reported revenue of £35.17 million for Interim.

Venture Life Group Earnings Headlines

Venture Life tightens share count with latest buyback
Pentagon magnet restrictions take effect January 1, 2027
A NASDAQ-listed company has signed a term sheet outlining a potential 75-year agreement with the U.S. Army. It would build and operate a rare earth processing facility on an active military base, with the Army receiving first right to production. The timing matters. New Pentagon restrictions on certain Chinese-origin rare earth magnets take effect January 1, 2027, while China controls more than 90% of global rare earth processing. The company's mine-to-magnet platform spans feedstock agreements, processing facilities, metallization technology, and downstream manufacturing, with initial commercial output targeted for 2027.tc pixel
See More Venture Life Group Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like Venture Life Group? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Venture Life Group and other key companies, straight to your email.

About Venture Life Group

Venture Life is an international consumer self-care company focused on developing and commercialising products for the global self-care market helping our consumers live a longer healthier and more rewarding life. Headquartered in the UK, the Group's product portfolio includes Balance Activ in the area of women's intimate healthcare, Earol® supporting ENT care, Lift and Glucogel product ranges for energy and glucose management and hypoglycaemia, plus the Health & Her product range supporting the hormonal lifecycle. The products, which are typically recommended by pharmacists or healthcare practitioners, are available primarily through health & beauty stores, pharmacies, grocery multiples and e-commerce channels and are sold globally. In the UK, Ireland and the USA these are supplied direct by the company to retailers, elsewhere they are supplied by the Group's international distribution partners.

View Venture Life Group Profile